An interventional study of Short fiber reinforced flowable resin composite restorations and Conventional resin composite restoration in Decay, Dental and Caries Class II, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 17 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-26.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Clinical performance of short fiber reinforced flowable resin composite restorations versus conventional resin composite restorations will be tested in posterior teeth (2y randomized clinical trial).
1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.
This study's planned enrollment of 70 is above the median of 60 across 915 interventional studies indexed under Dental Caries.
Browse Dental Caries studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
(everX Flow, GC Europe) + (Gaenial posterior, GC Europe
Other: Short fiber reinforced flowable resin composite restorations
(Gaenial posterior, GC Europe)
Other: Conventional resin composite restoration
reinforced flowable resin composite
Also known as: Ever X Flow
Microhybrid resin composite
Also known as: Gaenial posterior, GC Europe
Clinical performance (Alpha is the best score, bravo, charlie the worst score)
Modified USPHS criteria; . Post operative Hypersensitivity Secondary caries Gross fracture Color match Cavo-surface marginal discoloration Marginal integrity Proximal contact
Time frame: Change from baseline at 6, 12 ,18, 24 months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University